Compare ALKS & NAVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALKS | NAVN |
|---|---|---|
| Founded | 1987 | 2015 |
| Country | Ireland | United States |
| Employees | 2050 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 7.0B |
| IPO Year | 2012 | 2025 |
| Metric | ALKS | NAVN |
|---|---|---|
| Price | $45.24 | $27.04 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 20 | 15 |
| Target Price | ★ $56.21 | $30.80 |
| AVG Volume (30 Days) | 1.9M | ★ 2.4M |
| Earning Date | 11-03-2026 | 12-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,475,899,000.00 | $702,265,000.00 |
| Revenue This Year | $23.57 | $32.58 |
| Revenue Next Year | $6.58 | $24.21 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 30.82 |
| 52 Week Low | $27.00 | $8.11 |
| 52 Week High | $55.67 | $30.88 |
| Indicator | ALKS | NAVN |
|---|---|---|
| Relative Strength Index (RSI) | 59.90 | 67.93 |
| Support Level | $39.41 | $18.53 |
| Resistance Level | $45.20 | $28.08 |
| Average True Range (ATR) | 1.39 | 0.91 |
| MACD | 0.62 | 0.39 |
| Stochastic Oscillator | 96.63 | 88.63 |
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
Navan Inc is engaged in providing an end-to-end, AI-powered software platform for managing business travel and expense (T&E). The company's platform enables users to manage corporate travel bookings, payments, and expense processes, while providing tools for customers to control and optimize spending and for suppliers to access demand. Geographically, the company operates in the United States, the United Kingdom, and other countries, with the majority of its revenue generated from the United States.